We’re proud to announce that Weave is a gold sponsor of the Precision Drug Discovery Preclinical Summit in Boston! This event gathers industry leaders and innovators to discuss the latest advancements in drug discovery and regulatory practices.

📍 Visit Us at Our Booth!
Be sure to stop by our booth to meet the Weave team and learn more about how our AI-native regulatory automation solutions are transforming the landscape of drug development and regulatory compliance. Demos of our AutoIND and AutoCT products will also take place at the booth—don’t miss the opportunity to see our solutions in action!

📅 Talk Details
Topic/Title: Evaluating Time Savings in Regulatory Writing: A Scientific Comparison of Human and AI Approaches
Speaker: Lindsay Mateo, CCO
Date: June 9th
Time: 2:30 PM
‍

‍Summary of Case Study:

This talk explores the potential of generative AI to revolutionize regulatory writing, focusing on the comparative advantages of AI-assisted versus human-created content. By using data from an ongoing study with Takeda, we will discuss how AI tools can enhance the human drafting process in regulatory submissions. The conversation will highlight the potential for improving efficiency and maintaining quality standards, offering a practical perspective on the role of AI in shaping the future of regulatory writing.

Featured Topics:

• Exploring Human and AI Drafting Approaches
• Overview of an Objective Assessment Framework
• Insights into Enhancing Efficiency and Quality

We look forward to seeing you at the Precision Drug Discovery Preclinical Summit!

‍